Markets › India › NSE › MOLBIO

Molbio Diagnostics Limited

NSE:MOLBIOHealth TechnologyNSE:NIFTY_IPO

₹1,434.80−8.87%At closeAt close · Mon 19 Oct · ≈ AED 55.36 · Market cap $1.91B

MOLBIO · Ratios · TradingHolo

Ratio	FY2022	FY2023	FY2024	YoY
Gross margin	26.5%	43.0%	39.9%	−3.1 pts
Operating margin	5.9%	20.8%	21.4%	+0.7 pts
Net margin	−0.2%	12.2%	14.2%	+2.0 pts
EBITDA margin	15.4%	25.7%	25.8%	+0.2 pts
Return on equity	−0.1%	12.4%	15.0%	+2.6 pts
Return on assets	−0.1%	8.3%	9.9%	+1.6 pts
Return on capital employed	2.5%	19.8%	21.5%	+1.7 pts
Debt / equity	0.2×	0.2×	0.2×	−32.0%
Debt / assets	11.5%	15.0%	10.1%	−5.0 pts
Interest coverage	2.9×	12.0×	12.4×	+3.1%
Current ratio	2.4×	2.4×	2.1×	−12.3%
Quick ratio	1.0×	1.5×	1.1×	−24.5%
Cash ratio	0.0×	0.1×	0.3×	+300.8%
Asset turnover	0.3×	0.7×	0.7×	+1.9%
Inventory turnover	0.7×	1.5×	1.4×	−6.9%
Receivables turnover	1.7×	1.9×	3.7×	+90.9%
Dividend payout	0.0%	0.0%	0.0%	—

Margins, returns, leverage and liquidityUpdated 31 Mar 2025 ·

ⓘ